News Focus
News Focus
icon url

BooDog

05/09/18 9:02 AM

#227343 RE: frrol #227335

Would love to see double blinded prurisol data come out, on the brink of "any day now". And I like the timing of todays PR, put prurisol data out in pre-market Leo!!

Looking very good for brilacidin. Wonder which one of the CDA's will partner for the FDA meeting.

Message in reply to:

I wonder if this "data analysis conclusion" held up the FDA data submission and meeting, and its BTD verdict. (I think the clock starts upon submission: 60 days for BTD decision.) Company doesn't say here. We do know from March that the company was still "preparing for an FDA meeting", pulling together the CSR and a briefing package.

http://www.ipharminc.com/press-release/2018/3/15/innovation-pharmaceuticals-views-brilacidin-om-as-clearly-differentiated-compared-to-limited-competition-for-preventing-severe-oral-mucositis

Anyway, a nice B-OM update from the company.



It's no small job getting everything together. And now we're ready. Todays PR may not be a market mover but it certainly solidifies that they're ready for the next step. Possibly branching out into the EU as well.

[/GOOOOO $IPIX!!!!b]